• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOTECH HEMOSTREAM DIALYSIS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOTECH HEMOSTREAM DIALYSIS CATHETER Back to Search Results
Device Problems Structural Problem (2506); Infusion or Flow Problem (2964)
Patient Problems Hemorrhage/Bleeding (1888); Overdose (1988)
Event Date 10/15/2014
Event Type  malfunction  
Event Description
Diagnosis or reason for use: hemodialysis access.Life saving complaint.I want to post a complaint about hemostream dialysis catheter made by angiotech, because it has wrong design they may put patient's life at risk.The catheter mentioned above has a triple arterial lumen of which one clamp is controlling the three lumens, with one outlet.In case of occlusion (thrombosis) of one or two of these lumens and during giving the heparin lock at the end of dialysis the heparin will flow only through the patent lumen which ahs 1/3 of the size while we give amount enough to fill all the lumens.So the heparin lock will reach the blood stream in high amount (1/3 or 2/3 of the heparin lock will reach the blood stream depending on how many lumen are thrombosed 1 or 2).This is based on our experience with one hemodialysis patient.This patient was developing epistaxis, hematemesis and or melena many times at the day of dialysis.Patient a ptt was checked pre dialysis and 30 min before ending, results were in range, so a peripheral post dialysis sample was taken revealing very high aptt (more than 180 sec), so the heparin lock was suspected and investigated, revealing that the patient has thrombosed 2 lumens of his triple arterial lumen catheter, so heparin is going through one patent lumen only which will not compensate the whole amount of heparin, then 2/3 of heparin lock will reach blood stream, raising the patient aptt and increasing his bleeding tendency causing his epistaxis, hematemesis and melena.We started to give his heparin lock for the arterial lumen divided in three doses, every lumen is injected while clamping the other 2 lumens, with normal aptt results.Thank you.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEMOSTREAM DIALYSIS CATHETER
Type of Device
HEMOSTREAM DIALYSIS CATHETER
Manufacturer (Section D)
ANGIOTECH
MDR Report Key4226597
MDR Text Key20756038
Report NumberMW5038936
Device Sequence Number1
Product Code MSD
Reporter Country CodeSA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Physician
Type of Report Initial
Report Date 10/30/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/30/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ISORDIL: 10 MG BD; CACO3 TAB: TID; AMLODIPINE: 5 MG OD; RENAGEL: 800 MG TID; ASPIRIN: 81 MG OD; PLAVIX: 75 MG OD; COVERSYL: 5 MG OD
Patient Age32 YR
Patient Weight70
-
-